Vector Science and Therapeutics (TSXV:PAIN) Total Equity: C$0.97 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:PAIN Vector Science and Therapeutics Corp TSXV:PAIN
14 GF Score
Price C$1.55
View Full Analysis

What is Vector Science and Therapeutics Total Equity?

Vector Science and Therapeutics TSXV:PAIN -4.32% 14 Total Equity is C$0.97 Mil as of Feb. 2026. GuruFocus rates TSXV:PAIN with a GF Score™ of 14/100.

Vector Science and Therapeutics's total equity for the quarter that ended in Feb. 2026 was C$0.97 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Vector Science and Therapeutics Total Equity Historical Data

* Premium members only.

The historical data trend for Vector Science and Therapeutics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vector Science and Therapeutics Total Equity Chart

Vector Science and Therapeutics Annual Data
Trend Aug24 Aug25
Total Equity
0.00 2.38

Vector Science and Therapeutics Quarterly Data
Aug24 Nov24 Aug25 Nov25 Feb26
Total Equity 0.00 0.00 2.38 1.39 0.97
TSXV:PAIN
14GF Score
Vector Science and Therapeutics Corp TSXV:PAIN
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vector Science and Therapeutics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Vector Science and Therapeutics's Total Equity for the fiscal year that ended in Aug. 2025 is calculated as

Total Equity=Total Assets(Q: Aug. 2025 )-Total Liabilities(Q: Aug. 2025 )
=4.146-1.766
=2.38

Vector Science and Therapeutics's Total Equity for the quarter that ended in Feb. 2026 is calculated as

Total Equity=Total Assets(Q: Feb. 2026 )-Total Liabilities(Q: Feb. 2026 )
=2.263-1.29
=0.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of C$0.97 Mil mean?
Vector Science and Therapeutics (TSXV:PAIN) has a Total Equity of C$0.97 Mil as of Feb. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Vector Science and Therapeutics and its competitors.
Is Vector Science and Therapeutics' Total Equity too high?
Vector Science and Therapeutics' current Total Equity is C$0.97 Mil. Overall, Vector Science and Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Vector Science and Therapeutics' Total Equity compare to ABT and SYK?
Vector Science and Therapeutics' Total Equity of C$0.97 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Vector Science and Therapeutics and its competitors. Vector Science and Therapeutics's current Total Equity is C$0.97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vector Science and Therapeutics stock overvalued right now?
Vector Science and Therapeutics (TSXV:PAIN) has a current Total Equity of C$0.97 Mil. The current Total Equity is C$0.97 Mil. Vector Science and Therapeutics' overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Vector Science and Therapeutics (TSXV:PAIN), the current Total Equity is C$0.97 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vector Science and Therapeutics Business Description

Vector Science and Therapeutics Corp develops novel biomechanical devices and active transdermal drug and peptide delivery platforms to equip clinicians with non-systemic, localized interventions targeting a broad cross-section of diseases and conditions where systemic delivery of interventions compromises the therapeutic effect or introduces unacceptable harm.
14GF Score

Get the complete analysis for TSXV:PAIN

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.55
Price